Community/Retail

Promising results for lecanemab's efficacy in patients with mild cognitive impairment or mild dementia associated with Alzheimer disease were accompanied by reports of adverse effects associated with treatment.

Pharmacists should be vigilant in recognizing medications that are causing insomnia in a patient's profile or electronic medical record.

Mortality was highest among Asian, Black, and Hispanic populations, American Heart Association’s 2023 Statistical Update shows.

Consuming soy flour rich in B-conglycinin also promotes liver homeostasis, which may prevent atherosclerosis and fatty liver disease, research results show.

By setting a standard for prescriptions that improves member access, outcomes, and experience, we will establish a path forward for every facet of health care.

Increasing efforts have focused on treating COVID-19 among patients in rural areas, who can take advantage of traditional medicines.

Jim Whitman, senior vice president of member programs and services at the National Association of Chain Drug Stores (NACDS), discussed the upcoming NACDS 2023 Regional Conference and what attendees can look forward to.

Protect patients by evaluating VIGIV concentration and avoiding tearing of metal flange on vaccine vial.

Academic, community, first responder, government, and medical leaders call for better options to save lives.

Cases address questions about glycated hemoglobin A1C and hypoglycemia management.

When replaced with just 6 to 7 minutes daily of light-intensity exercise or sedentary behavior, data show poorer cognitive performance.

Respiratory syntactical virus burdens quality of life and can lead to long-term health outcomes.

Based on study findings, Moderna plans to submit for regulatory approval in the first half of 2023 for mRNA-1345, a novel vaccine for respiratory syncytial virus.

Study highlights the impact of individual expectations for positive and negative outcomes.

Compassionate use bridges gap between safety and patients' immediate need for biologics, devices, drugs, devices on spearhead of research and development.

Individuals with the virus had an 81 times higher risk of dying in the first 3 weeks of infection, and that remained 5 times higher for up to 18 months, analysis shows.

In a phase 3 trial, empagliflozin significantly reduced the risk of kidney disease progression or cardiovascular death in adults with chronic kidney disease by 28% compared with placebo.

Community pharmacies are an untapped resource in rural areas but need to market their services to effect changes in public health.

Products include drugs for patients with stroke, bacterial infections, and acute pain.

Data from a recent survey reflect a resounding shift toward the role of pharmacies becoming sites for primary care.

American Heart Association scientific statement recommends rapid evaluation for transient ischemic attacks.

Independent, scheduled review of Phase 3 Mosaico clinical trial finds a lack of efficacy in preventing the infection.

Patients on an SSRI were reportedly less likely to use positive or negative feedback to guide learning.

The Amazon Pharmacy service will also have pharmacists on-call 24/7, according to the announcement.

Viral vector vaccines and a booster can protect maternal women against the Omicron variant of COVID-19, but the mRNA vaccine with a booster dose appears to offer the best protection.

High cost-sharing is a large barrier to insulin access, as are aspects of the Inflation Reduction Act of 2022.

The oral SGLT2 inhibitor has been shown to reduce blood sugar and improve glycemic control as an adjunct to diet and exercise.

Can the profession afford not to retain expanded job roles for technicians in a post-pandemic era?

The new strategy would propose annual COVID-19 vaccines, much like annual flu shots.

Air pollution from the California Camp Fire are associated with increased rates of clinical; visits, according to new study results.